ABSTRACT A 52 year-old man with Erdheim-Chester Disease (ECD)(a non-Langerhans
polyostotic sclerosing histiocytosis) had next-generation sequencing (NGS) performed as …

Abstract 2832 Co-occurrence of a JAK2 V617F-positive myeloproliferative neoplasm (MPN)
with BCR-ABL-positive chronic myelogenous leukemia (CML) in a single patient is rare …

Increased prevalence of myeloid neoplasms in patients with Erdheim-Chester disease Page 1
©2013 MFMER | slide-1 Increased prevalence of myeloid neoplasms in patients with …

Myelofibrosis and chronic myeloid leukemia (CML) are myeloproliferative disorders (MPD)
of hematopoietic stem cell and characterized by clonal neoplastic proliferation of one or …

The myeloproliferative neoplasms (MPN) and myelodysplastic syndromes (MDS)
occasionally demonstrate overlapping morphological features including hypercellularity …

Screening of JAK2 V617F point mutation becomes more and more important in monitoring of
JAK2 positive MPN following stem cell transplantation. In an attempt to achieve the required …

A 54-year-old female patient developed acute erythroleukemia after an 8-year course of
primary myelofibrosis. The latter harbors the JAK2-V617F mutation and was treated with …

We read with interest the letter by Ohyashiki et al. 1 describing JAK2 V617F mutation in two
of six patients with myelodysplastic syndrome (MDS) developing myelofibrosis. The authors …

The mutational landscape of the Philadelphia chromosome negative chronic
myeloproliferative neoplasms (MPN) displays a high homogeneity as 70% of patients harbor …

A patient with myelofibrosis with myeloid metaplasia displaying the V617F mutation of the
JAK2 gene was given an allogeneic stem cell transplantation using a reduced‐intensity …